Notably, this approach could also target human CLEC9A-expressing DC to mediate the expansion of tumor self-antigen specific CD8+ T cells in PBMCs samples of melanoma patients in vitro, thereby underscoring the translational potential of this approach. The gene discussed is CD8A; the disease is neoplasm.